---
title: "Galsulfase - Maroteaux-Lamy Syndrome"
sidebar: mydoc_sidebar
permalink: db01279-mesh-d009087-1.html
toc: false 
---


Path ID: `DB01279_MESH_D009087_1`
{% include image.html url="images/db01279-mesh-d009087-1.png" file="db01279-mesh-d009087-1.png" alt="db01279-mesh-d009087-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C508864 | Galsulfase | Drug |
| GO:0003943 | N-acetylgalactosamine-4-sulfatase activity | BiologicalProcess |
| MESH:D006025 | Glycosaminoglycans | ChemicalSubstance |
| GO:0005764 | Lysosome | CellularComponent |
| MESH:D016464 | Lysosomal Storage Diseases | Disease |
| MESH:D009087 | Maroteaux-Lamy syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Galsulfase | PARTICIPATES IN | N-Acetylgalactosamine-4-Sulfatase Activity |
| N-Acetylgalactosamine-4-Sulfatase Activity | DECREASES ABUNDANCE OF | Glycosaminoglycans |
| Glycosaminoglycans | OCCURS IN | Lysosome |
| Lysosome | POSITIVELY CORRELATED WITH | Lysosomal Storage Diseases |
| Lysosomal Storage Diseases | POSITIVELY CORRELATED WITH | Maroteaux-Lamy Syndrome |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01279](https://go.drugbank.com/drugs/DB01279)
  - [https://en.wikipedia.org/wiki/Maroteaux%E2%80%93Lamy_syndrome#Treatment](https://en.wikipedia.org/wiki/Maroteaux%E2%80%93Lamy_syndrome#Treatment)
